The vestibular symptomatology of Machado-Joseph Disease

被引:0
|
作者
Elyoseph, Zohar [1 ,2 ,3 ]
Geisinger, Dario [4 ]
Zaltzman, Roy [3 ,5 ]
Mintz, Matti [1 ,6 ,7 ]
Gordond, Carlos R. [4 ,5 ,6 ]
机构
[1] Tel Aviv Univ, Sch Psychol Sci, Tel Aviv, Israel
[2] Max Stern Yezreel Valley Coll, Ctr Psychobiol Res, Dept Psychol & Educ Counseling, Jezreel Valley, Israel
[3] Imperial Coll London, Dept Brain Sci, Fac Med, London, England
[4] Tel Aviv Univ, Fac Med, Tel Aviv, Israel
[5] Meir Med Ctr, Dept Neurol, IL-44281 Kefar Sava, Israel
[6] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[7] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel
来源
JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION | 2024年 / 34卷 / 2-3期
关键词
Cerebellum; Machado-Joseph Disease; Spinocerebellar Ataxia type 3; Vestibular; Dizziness Handicap Inventory; Bilateral Vestibulopathy; SPINOCEREBELLAR ATAXIA TYPE-3; VESTIBULOOCULAR REFLEX VOR; HEAD IMPULSE TEST; ANXIETY; REHABILITATION; CLASSIFICATION; PERFORMANCE;
D O I
10.3233/VES-230038
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Machado Joseph Disease (MJD) is an autosomal dominant neurodegenerative disease. In previous studies, we described significant bilateral horizontal Vestibulo-Ocular Reflex (VOR) deficit within this population without any reference to the presence of vestibular symptomatology. OBJECTIVE: To evaluate whether, beyond cerebellar ataxia complaints, MJD patients have typical vestibular symptomatology corresponding to the accepted diagnostic criteria of Bilateral Vestibulopathy (BVP) according to the definition of the International Barany Society of Neuro-Otology. METHODS: Twenty-one MJD, 12 clinically stable chronic Unilateral Vestibulopathy (UVP), 15 clinically stable chronic BVP, and 22 healthy Controls underwent the video Head Impulse Test (vHIT) evaluating VOR gain and filled out the following questionnaires related to vestibular symptomatology: The Dizziness Handicap Inventory (DHI), the Activitiesspecific Balance Confidence Scale (ABC), the Vertigo Visual Scale (VVS) and the Beck Anxiety Inventory (BAI). RESULTS: The MJD group demonstrated significant bilateral vestibular impairment with horizontal gain less than 0.6 in 71% of patients (0.54 +/- 0.17). Similar to UVP and BVP, MJD patients reported a significantly higher level of symptoms than Controls in the DHI, ABC, VVS, and BAI questionnaires. CONCLUSIONS: MJD demonstrated significant VOR impairment and clinical symptoms typical of BVP. We suggest that in a future version of the International Classification of Vestibular Disorders (ICVD), MJD should be categorized under a separate section of central vestibulopathy with the heading of bilateral vestibulopathy. The present findings are of importance regarding the clinical diagnosis process and possible treatment based on vestibular rehabilitation.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [21] Machado-Joseph disease presenting as motor neuron disease
    Pinto, Susana
    De Carvalho, Mamede
    AMYOTROPHIC LATERAL SCLEROSIS, 2008, 9 (03): : 188 - 191
  • [22] Cervical and ocular vestibular evoked potentials in Machado-Joseph disease: Functional involvement of otolith pathways
    Ribeiro, Rodrigo Souza
    Pereira, Melissa Marques
    Pedroso, Jose Luiz
    Braga-Neto, Pedro
    Povoas Barsottini, Orlando Graziani
    Manzano, Gilberto Mastrocola
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 358 (1-2) : 294 - 298
  • [23] Strabismus and Micro-Opsoclonus in Machado-Joseph Disease
    Fatema F. Ghasia
    George Wilmot
    Anwar Ahmed
    Aasef G. Shaikh
    The Cerebellum, 2016, 15 : 491 - 497
  • [24] Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy
    Zaltzman, Roy
    Elyoseph, Zohar
    Lev, Nirit
    Gordon, Carlos R.
    CEREBELLUM, 2020, 19 (05): : 672 - 679
  • [25] Nonmotor and extracerebellar features in Machado-Joseph disease: A review
    Pedroso, Jose Luiz
    Franca, Marcondes C., Jr.
    Braga-Neto, Pedro
    D'Abreu, Anelyssa
    Saraiva-Pereira, Maria Luiza
    Saute, Jonas A.
    Teive, Helio A.
    Caramelli, Paulo
    Jardim, Laura Bannach
    Lopes-Cendes, Iscia
    Barsottini, Orlando Graziani P.
    MOVEMENT DISORDERS, 2013, 28 (09) : 1200 - 1208
  • [26] Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease
    Buhmann, C
    Bussopulos, A
    Oechsner, M
    MOVEMENT DISORDERS, 2003, 18 (02) : 219 - 221
  • [27] Planning Future Clinical Trials for Machado-Joseph Disease
    Morales Saute, Jonas Alex
    Jardim, Laura Bannach
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 321 - 348
  • [28] 3. Clinical Features of Machado-Joseph Disease
    Mendonca, Nuno
    Franca, Marcondes C., Jr.
    Goncalves, Antonio Freire
    Januario, Cristina
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 255 - 273
  • [29] Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy
    Roy Zaltzman
    Zohar Elyoseph
    Nirit Lev
    Carlos R. Gordon
    The Cerebellum, 2020, 19 : 672 - 679
  • [30] Profiling Microglia in a Mouse Model of Machado-Joseph Disease
    Campos, Ana Bela
    Duarte-Silva, Sara
    Fernandes, Bruno
    das Neves, Sofia Pereira
    Marques, Fernanda
    Teixeira-Castro, Andreia
    Neves-Carvalho, Andreia
    Monteiro-Fernandes, Daniela
    Portugal, Camila Cabral
    Socodato, Renato
    Summavielle, Teresa
    Ambrosio, Antonio Francisco
    Relvas, Joao Bettencourt
    Maciel, Patricia
    BIOMEDICINES, 2022, 10 (02)